Laboratory and clinical data: 32 blast populations
| UIN . | S3a . | BCL-2 . | Recovery (×105) . | PE . | Sensitivity . | Diagnosis . | Outcome . | Actin . | BLASTS (×10−9/L) . |
|---|---|---|---|---|---|---|---|---|---|
| 1088 | 1443 | 1212 | 7.6 | 14 | 9.30 | AML | F | 2983 | 3.4 |
| 1519 | 1925 | 3252 | 10.0 | 628 | 2.20 | AML | CR | 2219 | 34.0 |
| 1531 | 432 | 1332 | 8.7 | 12 | 6.70 | AML | F | 1439 | 29.7 |
| 1524 | 949 | 2939 | 5.4 | 30 | 77.80 | AML | NT | 1722 | 349.0 |
| 1523 | 1 | 1074 | 6.8 | 2 | >1.00 | CMML | F | 1514 | 10.0 |
| 1521 | 917 | 1978 | 10.0 | 375 | 38.00 | AML | F | 1486 | 220.0 |
| 1533 | 4 | 1499 | 5.1 | 940 | >1.00 | CMML | CR | 904 | 11.5 |
| 1532 | 5 | 1458 | 4.2 | 85 | >1.00 | AML | F | 1020 | 320.0 |
| 1530 | 4 | 1005 | 4.5 | 64 | >1.00 | AML | CR | 1572 | 9.0 |
| 1455 | 788 | 1838 | 9.1 | 116 | 5.70 | AML | F | 765 | 110.0 |
| 1448 | 180 | 2386 | 8.0 | 23 | 6.00 | AML | NT | 2603 | 172.0 |
| 1375 | 2731 | 3262 | 15.5 | 105 | 4.10 | AML | F | 1535 | 70.0 |
| 1468 | 124 | 1945 | 10.3 | 44 | >1.00 | AML | F | 2194 | 54.0 |
| 1456 | 3 | 1809 | 7.9 | 119 | 11.40 | AML | CR | 1795 | 159.0 |
| 1466 | 1058 | 2194 | 8.1 | 44 | 3.00 | AML | NT | 2451 | NA |
| 1331 | 1161 | 2106 | 14.7 | 845 | 2.30 | AML | NT | 1763 | 214.0 |
| 1373 | 2636 | 3704 | 11.1 | 1155 | 2.70 | AML | NT | 1944 | NA |
| 1064 | 27 | 368 | 7.2 | 46 | 20.00 | CMML | F | 2036 | 20.0 |
| 1002 | 2405 | 2222 | 15.0 | 146 | 7.90 | AML | CR | 1837 | 47.2 |
| 993 | 2208 | 2300 | 9.3 | 6 | >1.00 | AML | CR | 1942 | 1.4 |
| 1326 | 2093 | 1890 | 7.4 | 3 | >1.00 | AML | CR | 1993 | 18.6 |
| 1286 | 743 | 2846 | 9.9 | 4 | 17.90 | AML | F | 2049 | 111.0 |
| 1270 | 2266 | 2644 | 10.5 | 484 | 2.50 | AML | CR | 1817 | 9.3 |
| 1219 | 5 | 3326 | 8.8 | 326 | 5.90 | AML | CR | 2016 | 102.0 |
| 1128 | 1775 | 2064 | 12.6 | 605 | 9.60 | AML | CR | 1404 | 27.0 |
| 1179 | 2160 | 1536 | 9.0 | 93 | 2.90 | AML | CR | 1986 | NA |
| 1556 | 784 | 958 | 8.3 | 432 | 4.80 | AML | CR | 1867 | 40.0 |
| 1445 | 3162 | 2094 | 23.0 | 506 | 7.90 | AML | F | 1762 | 43.0 |
| 1440 | 918 | 2317 | 8.4 | 154 | 4.70 | AML | F | 1833 | NA |
| 907 | 1618 | 2835 | 9.3 | 196 | 91.30 | AML | F | 1796 | 88.0 |
| 904 | 2203 | 2002 | 5.8 | 907 | 5.95 | AML | F | 1844 | 7.0 |
| 899 | 3649 | 3719 | 14.7 | 131 | 10.40 | AML | NT | 2076 | 112.0 |
| UIN . | S3a . | BCL-2 . | Recovery (×105) . | PE . | Sensitivity . | Diagnosis . | Outcome . | Actin . | BLASTS (×10−9/L) . |
|---|---|---|---|---|---|---|---|---|---|
| 1088 | 1443 | 1212 | 7.6 | 14 | 9.30 | AML | F | 2983 | 3.4 |
| 1519 | 1925 | 3252 | 10.0 | 628 | 2.20 | AML | CR | 2219 | 34.0 |
| 1531 | 432 | 1332 | 8.7 | 12 | 6.70 | AML | F | 1439 | 29.7 |
| 1524 | 949 | 2939 | 5.4 | 30 | 77.80 | AML | NT | 1722 | 349.0 |
| 1523 | 1 | 1074 | 6.8 | 2 | >1.00 | CMML | F | 1514 | 10.0 |
| 1521 | 917 | 1978 | 10.0 | 375 | 38.00 | AML | F | 1486 | 220.0 |
| 1533 | 4 | 1499 | 5.1 | 940 | >1.00 | CMML | CR | 904 | 11.5 |
| 1532 | 5 | 1458 | 4.2 | 85 | >1.00 | AML | F | 1020 | 320.0 |
| 1530 | 4 | 1005 | 4.5 | 64 | >1.00 | AML | CR | 1572 | 9.0 |
| 1455 | 788 | 1838 | 9.1 | 116 | 5.70 | AML | F | 765 | 110.0 |
| 1448 | 180 | 2386 | 8.0 | 23 | 6.00 | AML | NT | 2603 | 172.0 |
| 1375 | 2731 | 3262 | 15.5 | 105 | 4.10 | AML | F | 1535 | 70.0 |
| 1468 | 124 | 1945 | 10.3 | 44 | >1.00 | AML | F | 2194 | 54.0 |
| 1456 | 3 | 1809 | 7.9 | 119 | 11.40 | AML | CR | 1795 | 159.0 |
| 1466 | 1058 | 2194 | 8.1 | 44 | 3.00 | AML | NT | 2451 | NA |
| 1331 | 1161 | 2106 | 14.7 | 845 | 2.30 | AML | NT | 1763 | 214.0 |
| 1373 | 2636 | 3704 | 11.1 | 1155 | 2.70 | AML | NT | 1944 | NA |
| 1064 | 27 | 368 | 7.2 | 46 | 20.00 | CMML | F | 2036 | 20.0 |
| 1002 | 2405 | 2222 | 15.0 | 146 | 7.90 | AML | CR | 1837 | 47.2 |
| 993 | 2208 | 2300 | 9.3 | 6 | >1.00 | AML | CR | 1942 | 1.4 |
| 1326 | 2093 | 1890 | 7.4 | 3 | >1.00 | AML | CR | 1993 | 18.6 |
| 1286 | 743 | 2846 | 9.9 | 4 | 17.90 | AML | F | 2049 | 111.0 |
| 1270 | 2266 | 2644 | 10.5 | 484 | 2.50 | AML | CR | 1817 | 9.3 |
| 1219 | 5 | 3326 | 8.8 | 326 | 5.90 | AML | CR | 2016 | 102.0 |
| 1128 | 1775 | 2064 | 12.6 | 605 | 9.60 | AML | CR | 1404 | 27.0 |
| 1179 | 2160 | 1536 | 9.0 | 93 | 2.90 | AML | CR | 1986 | NA |
| 1556 | 784 | 958 | 8.3 | 432 | 4.80 | AML | CR | 1867 | 40.0 |
| 1445 | 3162 | 2094 | 23.0 | 506 | 7.90 | AML | F | 1762 | 43.0 |
| 1440 | 918 | 2317 | 8.4 | 154 | 4.70 | AML | F | 1833 | NA |
| 907 | 1618 | 2835 | 9.3 | 196 | 91.30 | AML | F | 1796 | 88.0 |
| 904 | 2203 | 2002 | 5.8 | 907 | 5.95 | AML | F | 1844 | 7.0 |
| 899 | 3649 | 3719 | 14.7 | 131 | 10.40 | AML | NT | 2076 | 112.0 |
UIN, unique identifying number; Recovery, number of clonogenic cells recovered after 24 hours in culture with an input of 106 clonogenic cells; PE, plating efficiency; Sensitivity, ara-C D10 value; F, failure; CR, complete remission; NT, palliative treatment only; NA, not available.